Recent findings indicate that D-2HG in the microenvironment of GBM can be absorbed by CD8+ T cells and target lactate dehydrogenase (LDH), reducing the NAD+/NADH ratio in CD8+ T cells and resulting in diminished cytotoxicity and impaired interferon-gamma signaling. Here, CD8A is linked to glioblastoma.